verapamil and peptide phi

verapamil has been researched along with peptide phi in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bjøro, T; Gautvik, KM; Gordeladze, J; Haug, E; Iversen, JG; Ostberg, BC; Sand, O; Torjesen, PA1
Egan, JJ; Gardner, JD; Jensen, RT; Slimak, GG; Stark, HA1

Other Studies

2 other study(ies) available for verapamil and peptide phi

ArticleYear
Vasoactive intestinal peptide and peptide with N-terminal histidine and C-terminal isoleucine increase prolactin secretion in cultured rat pituitary cells (GH4C1) via a cAMP-dependent mechanism which involves transient elevation of intracellular Ca2+.
    Molecular and cellular endocrinology, 1987, Volume: 49, Issue:2-3

    Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Adenylyl Cyclases; Animals; Calcium; Cell Membrane; Cells, Cultured; Colforsin; Cyclic AMP; Membrane Potentials; Peptide PHI; Pituitary Gland; Prolactin; Rats; Secretory Rate; Thyrotropin-Releasing Hormone; Vasoactive Intestinal Peptide; Verapamil

1987
Effect of verapamil on the cyclic AMP-mediated pathway for amylase secretion in rat pancreatic acini.
    Pancreas, 1993, Volume: 8, Issue:2

    Topics: 8-Bromo Cyclic Adenosine Monophosphate; Amylases; Animals; Colforsin; Cyclic AMP; Intercellular Signaling Peptides and Proteins; Male; Pancreas; Peptide PHI; Peptides; Rats; Rats, Sprague-Dawley; Secretin; Vasoactive Intestinal Peptide; Verapamil

1993